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Worldwide, 70-90% of the population use alternative medicine for pain 
relief. 1 There are many forms of alternative medicines that are becoming popular 
with people experiencing pain. Most alternative therapies do not require invasive 
surgeries or use of medications. One form of alternative medicine that people use is 
magnetic therapy. Americans spend more than $500 million annually on magnets to 
treat pain.2 The estimated amount spent on magnetic therapy worldwide is $5 billion? 
Many people purchase magnets in stores or over the internet to use on their own 
without consulting a health care provider.3 However, many of the forms of 
alternative medicines, including magnets, do not have significant evidence to prove 
that they do indeed work. 
For hundreds of years, magnets have been used to alleviate pain. Magnets are 
said to improve fibromalgia,4 fracture healing,S carpal tunnel syndrome,6 pelvis pain,? 
diabetic foot pain,8,9 multiple sclerosis,1O osteoarthritis eOA),11 chronic low back 
pain, 12 rheumatoid arthritis pain,13 and tinnitus. 14 Magnets have even been 
acknowledged to help physical performancelS and increase range of motion. 16 
Philpott & Taplinl? showed that magnetic therapy can improve mood. Magnets are 
used in shoe insoles, heel inserts, mattress pads, bandages, belts, pillows/cushions, 
bracelets, and other jewelry.2 There has been some published research on the effects 
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of magnetic therapy but more is needed for the safety of the consumers. The medical 
community would benefit from more research on magnetic therapy in order to prove 
and standardize the treatment options. 
Purpose 
The purpose of this study was to evaluate the short-term effects of magnetic 
insoles on lower extremity (LE) OA pain and function. 
Research Questions 
1. Is there a significant difference in pain when an individual uses magnetic 
insoles? 
2. Is there a significant difference in function as self reported on the Short 
Form-36v2 (SF36) when an individual uses magnetic insoles? 
Significance 
The significance of this study was to assess if magnetic insoles decrease pain 
and increase functional abilities in people with OA of the LE. 
Null Hypotheses 
1. There is no significant difference in perceived level of pain with 
use of a magnetic insole, a nonmagnetic insole, and no insole. 
2. There is no significant difference in perceived level of function 
under the conditions of wearing a magnetic insole, a nonmagnetic 
insole, or no insole, as self-reported in the SF-36v2 in the physical 
and mental aggregate scores. 
2 
Alternate Hypotheses 
1. There is a significant difference in perceived level of pain with 
using a magnetic insole, a nonmagnetic insole, and no insole. 
2. There is a significant difference in perceived level of function 
under the conditions of wearing a magnetic insole, a 
nonmagnetic insole, or no insole, as self-reported in the SF-
36v2 under the physical and mental aggregates. 
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CHAPTER II 
REVIEW OF LITERATURE 
Osteoarthritis 
Osteoarthritis is defined as "a chronic joint disorder characterized by 
degeneration of joint cartilage and adjacent joints that can cause joint pain and 
stiffness.,,18 Osteoarthritis is also described by Goodman, Boissonnault, and Fuller 19 
as a slow, progressive degeneration of joint structures including articular cartilage and 
bone, with joint space narrowing. 19 Two out of 3 people in the United States over the 
age of 35 have signs and symptoms of OA. Due to the profound effects on the joints, 
many people with pain associated with OA seek medical and non-traditional 
approaches to pain management and improvement of function, including the use of 
magnetic therapy. 
The primary cause of OA has been found to be a defect in the articular 
cartilage which leads to degenerative changes in the articular surfaces of the weight 
bearing joints such as the hips and knees. Secondary causes of OA include trauma, 
infection, hemarthrosis, osteonecrosis, or other pathological conditions. 19 Described 
by Goodman, Boissonnault, and Fuller19 as being driven by mechanical forces but 
mediated by biomechanical processes, OA is an active disease process and generally 
not the result of general "wear and tear" on a joint. The disease process begins with 
the loss of cartilage which leads to joint inflammation and bony overgrowth with 
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osteophyte development. As there is no cure for OA, joint changes then lead to 
muscle weakness and atrophy, ligamentous laxity, and joint pain. Signs and 
symptoms of this disease process include: pain, deep ache, stiffness, crepitus, 
swelling, and decreased flexibility of the joint. 19 Although often relieved by rest, 
these symptoms can greatly impact a person's life and lead to the necessity for 
medical treatment. 
The most prevalent risk factors of OA are age,20 poor weight control,19 muscle 
weakness ,20 joint laxity,20 decreased bone density,19 genetics,19,20 local biomechanical 
factors,19 and a life of inadequate diet and lack of exercise. 18,21 In many cases, serious 
injury of a joint, especially the hip, has been found to lead to OA of the joint. 19 Sport 
activities can lead to degenerative changes of OA if they are high intensity, high 
impact, repetitive, and include twisting of the lower extremities. 19 
Factors placing individuals diagnosed with OA at high risk for decreasing 
function include proprioceptive inaccQracy, knee pain intensity, and a high Body 
Mass Index (BMI),zo Factors which increase a person's functional ability with OA 
include strength, mental health, high self-efficacy, increased social support, and a 
greater amount of aerobic exercise per week.2o Many of the people diagnosed with 
OA experience the need to reduce the amount of exercise and weight bearing 
activities in their lives due to pain in their joints. This sedentary lifestyle leads to 
increased weight and/or obesity, which puts more stress on the joints and begins a 
continuous destructive cycle. Combined with decreased lower extremity function, 
this cycle has been shown to increase the chances of osteophyte development in a 5 
year study,z2 
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Reducing the effects and progression of OA is a primary goal of treatment. 
Adequate amounts of Vitamin D and Vitamin C in the diet as well as early diagnosis 
and intervention has been found to slow the disease process. 19 Traditionally 
prescribed medications to decrease pain and degenerative changes associated with 
OA include COX-2 inhibitors, nitric oxide synthesis inhibitors, antioxidants, bone 
growth promoters, metalloproteinase and cytokine inhibitors, and gene therapy.19 
Additional medications can include aspirin, corticosteroids, intramuscular and intra-
. I . d·· . 23 2425 Add·· I d . . f· I artlCU ar sterOl InJectIOns. ' , Ihona recommen atIOns to Increase unctIOna 
ability include weight control and exercise combined with strength training. 19 Self 
management techniques that are increasing in popularity include TENS, acupuncture, 
hot and cold packs, pacing of activities, relaxation techniques, yoga, Tai Chi, goal 
setting, food supplementation such as glucosamine, and the use of walking aids or 
insoles. 19,23 Another therapy becoming popular for patients with painful OA is 
aquatic exercise which has been proven to reduce pain in weight-bearingjoints.25 
With the expanding popularity of these pain-reducing therapies, people are also trying 
other alternative therapies such as magnetic energy for pain reduction and improved 
function. 
Magnets 
Humans have been utilizing the power of magnetism for thousands of years. 
A lodestone (magnetite) mine dating back 100,000 years was located in Africa where 
magnetite was used in foods, potions, and creams to alleviate many dIfferent 
conditions.z6 It is thought that many civilizations, including the Chinese, Egyptians, 
Hebrews, Indians, and Greeks used magnets to cure illnesses, heal various conditions, 
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and relieve pain.26 In 1000 A.D., a Persian physician documented the use of magnets 
to relieve gout, muscle spasms, and other disorders. 14 Although the shape and size of 
magnets have changed, the basic principal in a magnetic therapy has remained the 
same. Natural (permanent) magnets are composed of a north pole, which has a 
negative charge, and a south pole which has a positive charge. Opposite poles attract 
each other and like poles repel. Magnets are able to produce their magnetic fields 
without an electrical current being present. Today, over 100 million people 
worldwide use magnetic therapy to counter the effects of pain, stress, and various 
conditions on the body.14 In Japan, magnetic therapy is popular due to research 
findings that show magnets to be effective for the treatment of pain.27 A natural 
magnetism exists in objects such as the loadstones used in Africa, the human body, 
and the sun. Dr. Kyoichi Nakagawa, director of Tokyo's Isuzu Hospital, believes that 
the proven decreasing magnetism of the sun causes a magnetic deficiency syndrome 
in the body which increases the population's need for additional magnetism in their 
lives.14,27 Symptoms he has associated with this syndrome include migraines, lack of 
energy, insomnia, general stuffiness, aches, pains, lower back problems, memory 
loss, and changes in heartbeat and blood chemistry.14,27 It is these factors that 
Nakagawa believes are the fundamentals behind the disease processes todayl4,27 and 
leads to the need for the application of magnetic therapy on the human body. 
Factors that can influence the effects of a magnetic field on the body include 
the duration of time the magnetic device is in contact with the body, strength and 
polarity of the magnet, geometric configuration, depth of penetration, and anatomical 
placement. 27 The recommended duration of magnetic therapy use for the therapeutic 
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effect of magnetism to occur varies by study. However, most studies agree that there 
is an immediate effect on the body when magnets are applied to it.6, 10, II , 12, 13, 14, 28 
When assessing length of time for effects to occur, it is important to consider the 
strength and polarity of the magnet because these factors can alter the affects on the 
individual. It is also important to consider factors such as age, the length and 
condition of the disorder, climate, and response of the body because these factors can 
affect the participants' response to magnetic treatment. Depending on these factors, 
treatment times can vary from seconds to months. Several studies report bodily 
changes due to magnetic therapy to be present after two weeks of utilizing the 
therapy.7, 11,29 
Polarity of a magnet refers to the direction of the magnetic force. 3o It has been 
shown that the negative polarity is safe for treatment of most disorders, especially 
when using high strength magnetic fields for a long exposure.3,30 Negative magnetic 
energy is used to normalize human cellular metabolic function , heal tissues, and calm 
the human body.3o When positive magnetic energy is used incorrectly, or overused, it 
can cause adverse effects on the tissues, or cause traumatic side effects such as 
altering nerve conduction or blood flOW. 14 
Magnetic fields pass freely through the body; the penetration of a magnetic 
field is directly related to the mass and the strength of the magnet. 14, 17 The strength of 
a magnet depends on the material used, shape, weight, size, and polarity. A gauss 
meter measures the strength of the magnet by the amount of iron-weight it can lift. A 
gauss unit (G) is the force of attraction that is measured at the surface of a magnet. 14 
In order for magnetic therapy to be effective, research shows that the strength should 
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be at least 500 G.3,27 An example of an insole, sold by American Magnet, has 15 
alternating vertical bands of lOOG each in the positive and negative fields. This 
alternating polarity produces a magnet with a weak strength of lOOG over all. 
Geometric configuration patterns of magnetic fields within a magnetic therapy 
device can include parallel lines, circles, triangular-board, or checkerboard patterns.!6 
The arrangement of the magnets used in products influences the strength of the 
magnets overall. The strongest pattern proven effective for a magnetic insole is a 
triangular-based grid.3 The magnetic insoles produced by American Magnet utilize a 
parallel line configuration. A study aimed to test the effectiveness of arrangements of 
static magnetic fields found that a whole-body, negative-field sleep pad reduced pain 
to a greater extent than a sham mat containing magnates of varying polarity. 
However, participants using either of the magnetic pads experienced improvements in 
functional status, pain intensity, and tender points. 
The effects of magnets on the human body are not proven in every case; 
however, many effects are theorized to occur in individuals treated with magnetic 
therapy. These effects include balancing the equilibrium between cell death and 
growth,24 increasing blood flow while increasing the delivery of oxygen and nutrients 
to the tissues,3! dilation of blood vessels,3! increase the production of white blood 
cells,2o reducing fluid retention and inflammation,24 and increasing connective tissue 
relaxation.32 It is also important to take into account the possibility of these effects 
causing unforeseen complications with pre-existing conditions. Magnetic therapy is 
not recommended for everyone. Contraindications include women who are pregnant 
as there is unknown effects on the fetus, consumers with an implanted device such as 
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an insulin pump, pacemaker, defibrillator, TENS unit, or cochlear implants should not 
use magnets due to the possibility of disruption of the magnetically controlled 
features of the devices, people who use a medication patch which magnetism may 
effect the delivery of the medication. Those persons taking anticoagulants or have a 
platelet disorder, Myasthenia Gravis, or hyperthyroidism should not use magnetic 
therapy due to the increased bleeding that can occur with application of magnetic 
fields. This caution also applies to persons with infections or wounds which may be 
adversely affected by the magnetic field. Magnetic therapy is also not recommended 
for those persons with cancer due to the increased circulation and possible spread or 
metastasis within the body. There are some potential side effects that have been 
reported from improper use of magnets, such as headaches, pain, insomnia, seizures, 
digestive problems, toxin release, tumor growth, dizziness, hyperactivity, and 
medication interactions.32 
Magnetic Therapy and OA 
Research shows conflicting results in the effectiveness of magnetic therapy for 
relief of pain from OA. One study reviewed 3 randomized control trials of pulsed 
electromagnets used on patients with OA of the knee and of the neck which 
demonstrated that magnets had a small to moderate effect on knee pain and a much 
smaller effect on neck pain.28 The researchers concluded that the current limited 
evidence does not show a clinically important benefit of pulsed electromagnets for 
treating OA of the knee or neck and that there is a need for larger trials to prove 
whether significant benefits do exist.28 
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Another trial utilizing pulsed electromagnet therapy with OA had participants 
use a placebo device or a Pulsed Electro Therapy (ET) device placed on or between 
the knees for 10 minutes 3 times per day?3 Pulsed ET significantly reduced pain, over 
a 6 week period in the treatment group, and did not produce any adverse effects. No 
improvements were noted with the placebo-treated group. The authors suggested 
further studies are needed to assess Pulsed ET for OA and other conditions.33 
A third method of using pulsed electromagnetic therapy had participants with 
OA of the knee lay on a pulsed electromagnetic mat or a sham mat for 30 minutes 
twice a day for 6 weeks. At the end of the 6 week trial, physical function scores were 
significantly improved for the treatment group compared with the sham group while 
pain and stiffness decreased for both groupS.34 Therefore, no significant difference in 
pain and stiffness was found between the groupS.34 
In a study utilizing static magnetic fields for treatment of pain associated with 
OA of the knee gave subjects a knee sleeve which either contained magnets, or was a 
placebo sleeve without magnets. Knee pain was measured at 4 hours, 1 week, and 6 
weeks. There was a statistically significant improvement in pain in the treatment 
group at 4 hours, but no significant difference was found at 1 week or 6 weeks.33 This 
study indicates that a 1 week or 6 week wearing period had no effect on knee pain 
compared to a 4 hour assessment. 
Marketing campaigns for magnetic insoles target individuals with diagnoses 
of OA of the foot, knee, and hip although limited research is available to determine 
the validity of the claims. Research concerning heel pain, however, has demonstrated 
results of decreased pain and increased function.35 One study that assessed the effects 
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of magnetic insoles on plantar heel pain found no significant differences in pain 
outcomes between participants who received either shoe insoles containing a magnet 
or insoles that were identical except for having no magnet. Participants wore the 
insoles at least 16 hours per week for 2 months and kept a daily pain diary to measure 
outcomes. Both groups experienced significant improvement in morning foot pain 
and in enjoyment of their jobs although no significant differences were found 
between treatment groupS.35 
Various magnetic therapy devices have been researched to analyze their effect 
on pain and function in people with OA. It is do to the limited research available 
concerning static magnetic fields for the improvement of pain arid/or function in 
persons with OA that further research is needed to evaluate magnetic therapy use in 
this population. Assessments used for the evaluation of pain and function in persons 
with OA are also key to the research of magnetic therapy's effects on a person and 
vary widely in their use in clinical settings. 
Evaluation Measures for Pain 
Several effective pain measures have been identified for various populations 
including the verbal, numerical, or line graph Visual Analog Scale (VAS),36 verbal or 
written reports,3? the McGill Pain Questionnaire,3? the modified pain chart,3? and 
pain diaries.3? The VAS (Appendix A) has been proven valid and reliable with many 
populations of people in pain38 and those with chronic pain36 such as the pain caused 
by changes associated with OA. Two versions of the VAS include the absolute and 
comparative scales.36 The absolute scale represents a person's pain at that moment in 
time while the comparative scale allows comparisons to previous scores to show 
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changes in pain over time.36 The absolute scale has demonstrated greater reliability in 
clinical testing than the comparative scale.36 Barker, Lamb, Toye, Jackson, and 
Barrington39 used the VAS pain rating scale to compare pain felt by people with OA 
and the radiographic findings indicating the disease progression. The researchers 
found that pain scores had greater clinical correlations with physical functioning than 
radiographic scoring.39 A study evaluating the effects of an aquatic exercise program 
on participants OA pain used the VAS to evaluate changes in pain over the course of 
the study.24 The VAS is widely used in OA literature to assess the pain felt by people 
with OA and the changes experienced through treatment.24,35,39 
Evaluation Measures for Function 
Radiographic scoring or grading of OA of the lower extremities is often done 
prior to joint replacement surgeries to assess the degree of OA involvement in the 
joint but may not be the optimal choice for analyzing changes in function of the 
persons with OA.22,39 The Kellgren and Lawrence scale of radiographic grades 
indicates the level of pathology from 0 to 4 with zero being no osteoarthritis 
development and 4 being severe involvement.39 Although these techniques are 
commonly used by surgeons, Barker, Lamb, Toye, Jackson, and Barrington,39 studied 
patients prior to joint arthroplasty and discovered that there were considerable 
variations in function, pain and power among participants with the same radiographic 
score. Two studies have found that pathological level of involvement or radiographic 
findings are not predictive of patient pain or function with OA leading to the 
necessity of the development of other testing procedures.39,40 
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Reproducible physical function tests which diagnose and track the effects of 
OA on the body include on-the-spot marching,41 walking up and down stairs,41 
completing a maximum number of strait leg raises,22 and a repeated chair stand 
exercise?O These examinations have been designed to assess the functional impact of 
OA on the person as a whole. They have also been proven to be effective in 
evaluating changes in patient's function through the course of treatment or disease 
progression.20,22,41 
Also effective for tracking changes in function and health are self-report, 
health related quality of life (HRQOL) questionnaires such as the Short Form-36 (SF-
36) (Appendix B), which make it easy for a patient and therapist team to assess a 
patient's progress in treatment. The SF-36 is a self reporting questionnaire covering a 
person's functional abilities and perceived quality of life. The second version of the 
Short Form-36, the SF-36v.2, was developed to be a more "international version" of 
the first edition and contains improved instructions and item wording, improved 
layout, increased comparability for cultural and translational adaptations, and an 
adapted 5-point scale as opposed to the original 7-point scale.42 The SF-36v.2 is 
recommended for population surveys, outcome research studies, controlled clinical 
trials, and clinical practice with individual patients. Questions on the SF-36v.2 are 
rated to indicate the level at which the participants health has effected different 
aspects of their life over the past week. For example, Question 1 asks "In general, 
would you say your health today is:" with response options: "1. Excellent, 2. Very 
Good, 3. Good, 4. Fair, or 5. POOr.,,42 Norm-based scoring algorithms have been 
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developed and researched to maximize reliability and validity of the SF-36v.2 making 
it a standardized test which is accepted in many fields. 42 
Salaffi, Carotti, and Grassi43 conducted a study which compared the Western 
Ontario and McMaster University (WOMAC) OA-specific questionnaire with the 
more broad SF-36. Their findings indicate that the WOMAC may be the instrument 
of choice when assessing only the consequences of knee and hip OA in elderly 
patients.43 The SF-36 was found to be better at assessing general function, non-
muscular co-morbidities and physical limitations in this population.43 Both the 
WOMAC and the SF-36 are self-reporting questionnaires with the WOMAC covering 
only the participants' perception on their pain, stiffness, and physical functional 
disabilities.43 Due to the multiple effects that magnets have on the body and the 
likelihood of co-morbidities, it is important that assessments of many factors are 
included in this study, leading to the utilization of the SF-36 as the functional 
assessment measure. Davey, Edwards, and Cochrane44 proved the SF-36 to have test-
retest reliability in participants with lower extremity OA. The mental health and role-
functioning areas of the SF-36 have been proven to accurately predict physical 
function outcomes in participants with OA in a 3 year study?O 
The SF-36v.2 assesses general health and quality of life including all parts of 
the body including the feet. Foot pathologies range from infections and ulcers, to 
deformities and cancers, making it important that feet are assessed whenever 
something new is added to the shoe.45 Also, co-morbidities such as diabetes are 
common in people with OA and it is highly recommended that foot health be assessed 
regularly to prevent skin breakdown and monitor sensory changes. 
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Foot Screenings 
Routine foot screenings are important for the vast majority of the older 
population due to the rising number of people with diabetes and the fact that there is 
no treatment available for peripheral neuropathy caused by diabetes.46 It is estimated 
that 15% of all hospital admissions for diabetic patients are related to peripheral 
infections.45 By identifying those at risk for ulceration, preventative measures can be 
taken to avoid any changes in peoples' feet prior to complications or diabetic 
diagnosis. To identify those at high risk of ulceration, it is imperative that an 
effective screening tool is designed for screening purposes.46 A common device used 
to assess lack of protective sensation in many populations is the Semmes-Weistein 
monofilaments. This set of 20 nylon filaments with standardized lengths and 
diameters, which buckle at a designated, reproducible force.46 Authorities recommend 
that 10 sites are tested on each foot with 9 sites on the plantar surface and 1 site 
between the first and second toes to assess all dermatomes on the foot. 47 Singh et al47 
found that only 4 testing sites are needed to adequately assess sensation changes and 
has proven reliable in detecting changes in 90% of the population. 
In addition to sensation testing, assessments for foot pathologies including 
ulcerations, pedal pulses, and deformities are needed for people with OA of the LE. 
Ulcers of the feet occur when continuous trauma is applied to a specific area leading 
to a loss of protective adipose tissue.48 Nutritional supply to the area is then 
diminished in people with vascular disorders or may occur through neuropathy.48 
Infections may cause few if any symptoms leading to delay of treatment and 
increasing involvement of surrounding tissues.45 The warm, moist environment 
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experienced by feet when confined in shoes for several hours each day increases the 
likelihood for infections.48 It is also important that pedal pulses be assessed due to the 
prevalence of Peripheral Artery Disease in the aging population and the effects of this 
disease on a person's feet. Although truly absent pedal pulses can only be assessed 
using Doppler technology, notations of diminished or absent pulses with palpation 
should be referred to a physician for further assessment.45 Absent, diminished, and 
normal pulses identified with palpation is a standardized and reproducible physical 
assessment.45 Although unlikely in smaller vessels, bruits in the artery should also be 
recorded if present.45 Common foot deformities include hallux valgus, claw toes, and 
nail pathologies which may become worse with the addition of something in the 
shoe48 such as an insole. 
Magnetic insoles are believed to benefit people with foot, knee, hip, and low 
back pain through the magnetic properties described previously. Because it is 
common for OA to affect these joints of the LE, magnetic therapy may be a modality 
to assess when analyzing various treatment options for people diagnosed with OA. 
Therefore, it is the focus of this study to evaluate the short-term effects of magnetic 





Subjects were recruited by advertisement (Appendix C), word of mouth, and 
personal acquaintances of researchers. During the initial phone conversation with 
potential subjects, general qualification questions were asked and size of shoe was 
obtained from the participants. Insoles were purchased prior to each participant's 
first meeting based on the size each had reported during the initial conversation. 
Potential subjects were informed of details of the study and given the opportunity to 
ask questions and discuss concerns prior to deciding to participate in the study. 
Approval for the use of human subjects for this study was obtained from the 
University of North Dakota Institutional Review Board. (Appendix D) 
Ten people volunteered to participate in the study, 2 were excluded due to 
time conflicts and not meeting inclusion criteria. Eight subjects (3 males, 5 females; 
mean age of 55.85 years) met the necessary criteria to be included in this study: 
1. Previously diagnosed with OA in one or more joints in their LE 
2. Age 18 years or older 
3. Physical pain in the lower extremity 
4. No implanted metal device in the foot or ankle 
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5. No pacemaker, cochlear implant, or other implanted device which have 
possible adverse affects from external magnetic field 
6. No known myasthenia gravis, hyperthyroidism, platelet disorder, spinal 
neoplasm, cancer, or pregnancy at the time of the study 
7. Not on anticoagulant medications 
8. No evidence of adverse findings in the foot examinations and not currently 
using foot orthotics 
9. Participants must also be able to rate their pain on the Visual Analog Scale 
(Appendix A) and complete the SF-36v2 Functional Assessment 
Questionnaire (Appendix B). 
Subjects were not excluded from this study due to prior joint arthroplasty of the knee 
or hip or current use of over-the-counter or prescription medications. 
Instrumentation 
At the beginning and end of each 2 week insole-wearing period, participants 
completed the VAS, SF-36v.2, and had their feet assessed by the investigators. Pain 
was assessed using the 0-10 V AS with 0 signifying no pain and 10 equaling the most 
extreme pain they can imagine experiencing at that time. The V AS has been 
established as valid and reliable.38 
The SF-36v.2 is a self-report questionnaire used in assessment of perceived 
physical and mental functioning prior to and during the wearing periods. The SF-
36v.2 contains 36 questions with 1-3 and 1-5 ratings for functional abilities. 
Research has demonstrated that the SF-36v.2 is useful in assessing functional changes 
over time in people diagnosed with OA.42,43,44 
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Participants' foot health data was collected using a foot assessment (Appendix 
E) devised by the investigators to assess skin and nail integrity, sensation, and 
circulation. Adverse reactions of the feet in these areas would have been identified 
by this assessment. 
Procedure 
Potential participants completed a Participant Survey (Appendix F) which was 
used in assessment of inclusion criteria and resultant demographical analysis. Once 
potential subjects were screened for the inclusion criteria and agreed to participate in 
the study, each participant signed the Consent Form (Appendix G) and were given a 
copy for their records. The individuals recruited for participation in this study were 
informed that their participation was voluntary and that they could withdraw at any 
point during the study without consequences. Subjects then completed the pain 
assessment on the VAS, the SF-36v2, and received the initial foot assessment. 
Eligible participants were randomly assigned to 1 of 2 groups depending upon which 
insoles they were to wear first, magnetic or non-magnetic. 
The magnetic insoles were those produced by American Magnet and had a 
cumulative strength of 100G. The insoles were made up of 15 bands of alternating 
polarity running the length of the insoles. Five participants wore these insoles during 
the first wearing period. The non-magnetic insoles were Dr. Scholls Cushion 
Insoles. Three participants wore the non-magnetic insoles during the first wearing 
period. 
For the initial meeting, participants were asked to wear the shoes in which 
they would wear the insoles at least 8 hours each day during the study. The 
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investigators then fit participant's shoes with the insoles which each had been 
randomly assigned to wear. If needed, the insoles were cut to fit the size of the shoes. 
Once fit of the insoles had been established, each participant was given a Wearing 
and Activity Log (Appendix H) on which they were asked to record the hours they 
wore their shoes with the insoles each day and general activities performed while 
wearing the shoes with insoles. 
After 1 week, each participant was called by an investigator and was asked to 
rate their pain on the VAS. Participants were questioned about the fit of the insoles 
to identify possible adverse affects which may have been caused by the insoles. The 
participants were given the opportunity to ask any questions that had come up over 
the past week. 
At the end of 2 weeks, participants met with a researcher, reported their pain 
on the VAS, and completed the SF-36v2. Participants' feet were assessed at this time 
to identify any adverse affects that may have occurred during the insole wear. 
Participants also turned in their completed Wearing and Activity Log to the 
researcher. 
For a period of at least 1 week following the first trial, no insoles were worn 
by the participants. At the end of this time period, each participant returned to be refit 
with the opposite type of insoles from the type worn during the first 2 weeks of the 
study. Each subject gave a pain rating on the VAS, filled out the SF-36v2, and 
received a new Wearing and Activity Log. The foot assessment was completed by 
the investigators at that time to assess any changes that may have occurred during the 
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previous time frame and to identify any reason for the participant to be discontinued 
from the study. 
Following a week of wearing the second pair of insoles, each participant was 
again called by an investigator. Participants were given the opportunity to express 
any concerns and were asked for a pain rating on the VAS. Participants were 
questioned about the fit of the insoles to identify any possible adverse affects caused 
by the insole wear. 
At the end of the second 2 weeks, each participant was assessed by an 
investigator for a final time. Pain was reassessed with the VAS, and overall function 
was reassessed with the SF-36v2. Participants also turned in their Wearing and 
Activity Logs to the investigators. Participants' feet received the final foot 
assessment at that time to ensure they had maintained the health of their feet and had 
no adverse affects caused by the insoles. Participants were allowed to keep the 
insoles they wore as compensation for completing the study. 
Data Analysis 
Transformation of data was completed following the standardized procedure 
for analyzing the SF-36v.2, and statistical analysis was completed using the Statistical 
Package for Social Sciences (SPSS) version 11.5.49 The independent variables 
identified for this study were the type of insoles worn by the participants. The 
dependant variables were the participants' pain and level of function. Univariate 
Analysis of Variance (ANOVA) with a repeated measures design was completed for 
pain on the V AS and the 2 factors, physical and mental aggregates, identified through 





All 8 participants completed the study; demographics are presented in Table 1. 
All participants' self-reported wearing times averaged above the recommended 8 
hours per day for the total 2 weeks in each wearing condition. No mean difference 
(x= 9.62, SD=1.87) was found in the hours participants wore the magnetic or 
nonmagnetic insoles. Thus leading to the conclusion that the hours worn did not 
effect data analysis and had no alternate effect on the participants' pain or function 
data. 
Pain 
The means and standard deviations for pain scores were not statistically 
significant for demonstrating a decrease in participants' pain during the study (Table 
2). Pain scores were entered and analyzed using the univariate, repeated measures, 
ANOV A. The tests of between-subjects effects of pain revealed no significant 
difference between participants who wore magnetic or non-magnetic insoles during 
either of the 2 wearing periods [F(5,I9)=1.382, p=.275, power=.38I] (Figure 2). The 
insoles the participants wore, magnetic or nonmagnetic, had no effect on participants' 
pain level during either of the 2-week wearing periods or during the no-insole 
wearing period. 
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Table 1: Participant Demographics 





Hip and knee pain 4 
Hip, knee, and low back pain 1 
Knee pain only 3 
Joint Arthroplasty: 2 
Unilateral hip arthroplasty 1 
Bilateral hip arthroplasty 1 






Previous magnetic insole use 0 
Participant beliefs in magnetic therapy 
for pain control: 
Believed in magnetic therapy 2 
Did not believe in magnetic therapy 2 
Did not respond 4 
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Table 2' Pain Means and Standard Deviation 
Time, Insole Mean Standard Deviation 
Initial, no insole 3.63 2.26 
First wear, non-magnetic insole 2.33 1.15 
First wear, magnetic insole 3.80 1.30 
Post break, no insole 2.63 2.13 
Second wear, non-magnetic 3.6 1.95 
insole 






• • • • ••• 
4 • • 
0 • • 1; condition • • • • • !!I • 1· • • 2 • • • • I. • • o no insole • • I ••• I c 'cu • 
c. 0 .l. o no rragnet 
0 
~ I 0 
L{) 
-2 o rragnet 0> 
N= 8 3 5 8 5 3 
pre-insole post 1 st wear post rest post 2nd wear 
survey time 
Figure 1: The 95% confidence intervals of the means 
for pain scores reveal no significant statistical change 
in that the intervals overlap greatly and represent no 
change between the reported pain before or after any 
of the insole use. 
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Function 
There was no significant difference between the physical (Table 3) or 
mental (Table 4) aggregate means and standard deviations of the magnetic and 
nonmagnetic insole wearings. Tests of between-subjects effects on the 
transformed physical aggregate scores revealed no statistically significant 
difference in physical scores between wearing times [F(5,19)=.695, p=.634, 
power=.199] (Figure 3). Also, tests of between-subject effects on 
transformed mental aggregate scores revealed no statistically significant 
changes in mental scores between wearing times [F(5,19)=.338, p=.884, 
power=.115] (Figure 4). Therefore, perceived health and role function was 
unaffected by the insoles worn by the participants. 
Foot Assessments 
The Foot Assessments that were completed at the beginning and end 
of each insole wearing period showed objective changes with only 1 
participant. The monofiliament tests for sensation and the dorsal/pedal pulses 
assessment showed no changes with any participant. However, the skin 
integrity check showed changes in one participant. One participant developed 
blisters on her feet during the first week of the second wearing time, the 
magnetic insole period. This participant was not removed from the study 
because she chose to continue wearing the insoles and reported her pain was 
unaffected by the blisters which were almost healed by the final assessment. 
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Table 3: Physical Aggregate Means and Standard Deviations 
Time, Insole Mean Standard Deviation 
Initial, no insole 39.59 7.43 
First wear, non-magnetic insole 38.87 6.32 
First wear, magnetic insole 41.43 5.80 
Post break, non insole 40.79 6.45 
Second wear, non-magnetic insole 41.52 7.04 





11 "-C> T C> ttl • •• ••• cti • • • () • , • 'Ci) • • 
>- • I!I III I condition 
.!: 40 ~ I • 11 0- II • • • '0 • • • • Q) • .1. E • ..L o no insole "- ••• 0 - I en 30 c 
ttl 
"- o no rragnet -
() 
I eft. --
LO 20 o rragnet 0> 
N= 8 3 5 8 5 3 
pre-insole post 1st wear post rest post 2nd wear 
survey time 
Figure 2: 95% confidence interval of the means of 
each test condition regarding physical aggregate scores. 
As this visual representation of the data depicts the error 
bars overlapping, this demonstrates that the difference 
between the means in not statistically significant for the 
conditions. 
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Table 4: Mental Aggregate Means and Standard Deviations 
Time, Insole Mean Standard Deviation 
Initial, no insole 53.14 7.89 
First wear, non-magnetic insole 58.16 1.09 
First wear, magnetic insole 53.09 6.41 
Post break, no insole 53.97 5.08 
Second wear, non-magnetic insole 52.03 5.49 
Second wear, magnetic insole 58.84 3.30 
70 
T 
Q) • ..... co I 0') Q) .... 
TI • 0') 60 , 0') ••• co • • ••• 
Ii co • 11 • ..... • • c condition Q) • • • • E • , iii "0 0 • • Q) • • • • E • • 1· 50 • I • o no insole .... • • •• 0 ..... • • en • I c • I co ••• .... o no rragnet ..... -0 
I ~ 0 
LO 40 o rragnet 0> . 
N= 8 3 5 8 5 3 
pre-insole post 1st wear post rest post 2nd wear 
survey time 
Figure 3: Data demonstrates that with small sample 
size and overlapping effort bars, the 95% Confidence 
Intervals of the means were not statistically significant 
between testing conditions. 
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CHAPTER V 
DISCUSSION/LIMITATIONS AND CONCLUSION 
The use of magnetic and non-magnetic insoles for pain relief and 
improvement of function in people with OA pain was not supported by the findings in 
this study. Statistical data revealed that there was no significant difference in pain or 
function as reported on the VAS and/or SF-36v2 under any of the testing conditions. 
Participants experienced no statistically significant changes in pain or function from 
initial testing to after wearing magnetic or non-magnetic insoles, and after a no-insole 
wearing period. Both mental and physical aggregate scores on the SF-36v2 revealed 
no statistical change between conditions. This evidence supports the null hypothesis; 
magnetic and non-magnetic insoles had no effect on pain and function in people with 
OA in this study. 
Participant factors which could have affected the outcome of this study 
include: age range of participants and effects of OA on their person, activities 
engaged in, beliefs in magnetic therapy, and additional personal choices in regards to 
how they wore their insoles. Additional factors that could have influenced results 
include: evaluation procedures, small sample size, length of time and time of year that 
the insoles were worn, strength of the magnets, and the fact that the study was not 
blinded. Individually or in combination, all of these factors had the potential to limit 
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the effects of magnetic insoles on the participants' pain and/or function during the 
study. 
The age of participants in this study was approximately 55 years, and because 
. of the small sample size, no statistical data was done to determine age related OA 
changes. With OA, the longer the person has pathological changes within the joint, 
the more intense the symptoms may become over time. The participants' initial 
severity of pain (x: 3.63, SD: 2.26) may have had an effect on the results when 
assessing changes of pain and function. 
Participants' daily activities were not restricted during the study, only the 8 
hours of daily insole wear time was recorded and reported by the participants. 
Although participants were asked to fill out logs to assess their average activities, 
these activities were not controlled, and many participants were not descriptive of 
their activities on the forms. This difference in activities may have made an impact in 
their pain and function. Subjects may have been more active these summer months or 
had different types of activities in their lives. This activity could have caused 
increased or decreased pain and changes in functional abilities. Future studies may 
wish to standardize activities or consider a pedometer to track level of activity of the 
participants over the course of the study. 
This study was not blinded, and the subjects knew which insole they were 
wearing during each time period. Preconceptions of alternate therapy could have had 
a psychological effect on subjective data. On the initial survey, a question asked if 
each believed in magnetic therapy. Four participants chose to leave this question 
blank, 2 reported positive feelings towards magnets use for pain relief, and 2 
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disagreed with the potential pain relief qualities of magnetic therapy.(Table 1) The 
researchers did not attempt to influence participants' beliefs during the initial intake 
or during the course of the study. 
The participants also provided limitations for this study; they made personal 
choices that may have influenced data reporting. For example, one participant chose 
to wear her insoles with her sandals. Although recommended to wear shoes, this 
participant developed blisters from gluing her insoles to the bed of her sandals to 
make them stay put. Another participant, who did not wear orthotics at the start of 
the study, chose to insert her insoles over orthotics at some point during the first week 
of the magnetic insole wear. This change could have affected the position of the 
insole relative to the foot. Specific initial instruction for participants regarding these 
unanticipated actions or guidelines for researchers' data inclusion following in these 
types of circumstances would benefit future studies on insole use. 
Data was reported subjectively by the participant, and there were no objective 
recordings done to ascertain diagnosis and progression. Objective data, such as 
radiographs39,40 or physical function testing, 20,22,41 may have demonstrated changes 
due to the insoles that the participants were unaware of in their subjective reports. 
Investigators did not request that participants provide written proof from their 
physicians of the diagnosis of OA, and no functional tests were performed to quantify 
the extent of OA involvement in the participants' LE. Pain is difficult to measure 
since it is subjective and depends on multi-causative factors. 39 
The small sample size decreased power in data analysis. A larger sample size 
may be warranted to demonstrate the effects on a population with OA. Also, no 
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analysis was done on the placebo effect in this study. A blinded study may have 
altered participant's self-reported pain and function differences. 
The subjects wore the magnetic insoles for 2, 2-week time periods with a 
minimum of 1 week break between wearing periods. Although researchers have used 
a 2-week time frame and stated that significant differences in subjects symptoms were 
found, the results of this study do not support the findings that a 2 week time period is 
sufficient for demonstrating changes in pain and/or function.7, 11,29 Pain and function 
scores may have shown greater changes with a longer wearing period. Due to the 
subjects wearing the insoles during different times of year, weather may also have 
had an effect on symptoms along with the shoes participants chose to wear during this 
time period. 
Other factors that had the potential to influence results were the magnetic 
strength of the insoles, configuration, and polarity. Compared to the recommended 
500 G 3,27 strength of magnetic insole, the strength of the American Magnet insoles 
were weak, measuring only 100 G. A triangular-based grid configuration3 has also 
proven most effective for magnetic therapy treatments. This study used the American 
Magnet insoles which were arraigned in a parallel band configuration. Negative 
polarity is recommended to increase human cellular metabolic function, heal tissues, 
and calm the human body.3o The American Magnet insoles consisted of alternating 
bands of positive an negative polarity. 
Clinical Implications 
Due to the high number of people using magnetic therapy, it is important for 
health providers to be educated and aware of the effects of magnetic therapy. Patients 
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who may be using alternative therapies, such as the use of magnetic therapy, may not 
be aware of possible side effects and contraindications to the therapy they have 
chosen to apply to their body. By encouraging patients to report alternative therapy 
use to providers, providers can discuss research with their patients on what has been 
shown to be effective and minimize potential adverse affects. With many types of 
pain relief available, it is important for clinicians to be aware of the available uses and 
effects of these therapies. 
Conclusion 
Under this study's conditions, we found no significant difference in pain with 
the use of magnetic insole, nonmagnetic insole, and no insole. We also found no 
significant difference in function under the conditions of wearing a magnetic insole, 
nonmagnetic insole, or no insole as self-reported on the SF-36v.2 under the physical 
and mental aggregate scores. Statistical analysis revealed that no significant 
difference was found in mental and physical aggregate scores during any of the 
wearing periods. This data gemonstrated that the participants in this study felt no 
decreases in pain or increases in functional abilities during this study as reported on 
the VAS and SF-36v.2. 
As we discovered with this study, manufacturers are marketing products to 
groups of people who may not experience any significant change in their pain or 
functional abilities due to the product they purchase. Providers may be asked to 
educate patients on the potential effects of these therapies so that consumers can 
make educated decisions about what they choose to use on their body. As people 
today are increasing their use of alternative therapies, including magnetic therapy, it 
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is important that more evidence based research is done to determine the possible 
effects and benefits of these therapies. Potential areas for further research include: 
age of participants, activities participants engage in, length of time the magnets are 
worn, strength of the magnets, and a larger sample size. Additional evaluation 
procedures to examine the involvement of OA in the participants' LE and functional 





Participant Pain Questionnaire 
Circle the number that describes your pain today: 
o 1 2 3 4 5 6 7 
None Some Moderate 
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8 9 10 
A Lot Severe 
APPENDIXB 
Your Health and Well-Being 
This survey asks for your views about your health. This information will help 
keep track of how you feel and how well you are able to do your usual 
activities. Thank you for completing this survey! 
For each of the following questions, please mark an !:8J in the one box· that 
best describes your answer. 
1. In general, would you say your health is: 
Excellent Very good Good Fair Poor 
2. Compared to one year ago, ho~ would you rate your health-in g~neral 
~? 
SF-36v2™ Health Survey © 1996, 2000 by QualityMetric Incorporated and Medical Outcomes Trust. All Rights Reserved. 
SF-36® is a registered trademark of Medical Outcomes Trust 
, ... ,... ... , ....... t • .... '" 
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3. The following questions are about activities you might do during a typical 
day. Does your health now limit you in these activities? If so, how much? 
... I 
Yes, Yes, No, not 
limited limited limited 
a lot a little at all 
• Vigorous activities, such as running, liftIng 
heavy objects, participating in strenuous 
sports ............ ... ... ........ .... ...... ... ..... .... ..... ........... ... . 01 ......... .. ........ 02 .......... .. ...... 03 
b Moderate activities, such as moving a table, 
pushing a vacuum cleaner, bowling, or 
playing golf ................................................ .. .... ..... 01 ... ................ 02 .................. 03 
e Lifting or carrying groceries .................................. 01. .................. 02 .................. 03 
d Climbing several flights of stairs ...... ... .. .. ..... ....... ... OI. .... .... .......... 02 ........... /.. ... 03 
e Climbipg one flight of stairs ..... .............................. 01 ... ....... .. .. .. ... 02 ....... .......... . 03 
f Bending, kneeling, or stooping ............ ...... ............. OI. ...... .. .......... 02 .................. 03 
g Walking more than a mile ............................ ...... .... 01. .................. 02 .. ............ .... 03 
h Walking severalbundred. yards .............................. 0, ................... 02 .. ................ 03 
i Walking one hundred yards ......... .. ......................... 01. ........ ...... .... 02 ................ .. 03 
j Bathing or dressing yourself.. .......... ....................... OI. .. .. .. ........ .... 02 .. .... .. .......... 03 
Sf'~36v2'·M Health Survey © I 'J96; 200tl by QualityMetric IncotpOrated and Medical Outcomes 'l'rust. All Rights Reserved. 
SF-36® is i! regi;l~ed ltitdenwk ufMedical OmOOines Tfu.l ' . . 
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4. Duting the past 4 weeks, how much of the time have you had--any of the 
following problems with Y01Ir work or other regular daily activities as a 
result of your physical health? 
• Cut down on the amount of time you spent 
All of Most of Some of A little None of 
the time the time the time of the the time 
time 
on work or other activities ........... .. .... ........ .............. 01. ........ 0 2 ........ 03 ... .. .. .. 0 4 ......... Os 
b Accomplished less than you would like ... ... ... ..... ... . 0 1. ........ 02 ........ 03 ......... 04 ......... Os 
c Were limited in the kind of work or other 
activities ................ = ....... ......... ... .. .. .... .. .. .... 0, ..... .... 02 .... .... 03 ... ...... 04 ... ...... 05 
d Had difficulty performing the work or other 
activities (for example, it took extra effort) .... ..... . 0, ......... 02 ........ 03., ..... .. 04 .. ....... Os 
5. During the past 4 weeks, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of any emotional problems (such as feeling depressed or anxious)? 
• Cut down on the amount oftime you spent 
Al1 of Most of Some of A little None of 
the time the time the time of the the time 
time 
on work or other activities .. ........ ..... .. .. ..... ............. 0, .. .. ... .. 02 ........ 03 ... ...... 0 4 ........ Os 
b Accomplished less than you would like .. ... .... ....... 0, .... .. ... 02 ........ 03 ..... .... 04 .... .. .. Os 
c Did work or other activities less carefully 
than usual. .... .. .. .. ... ... ... ..... .. .. ... ... ..... .. ...... ... .. ..... .. ... 0, ......... 0 2 ........ 03 .. ... .... 04 ........ Os 
SF-36v2TM Health Swv!')'@ 1996,2000 by QualityMetric Incorporated and Medical Outcomes Trust. All Rights Reserved. 
SF-36® is a registered tmdemark o~Medical Outcot,nos Trust 
~.,... ... , ... ..." , 1 TY"'" . "" I"l' 
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6. During the past 4. weeks., to what extent has your pbysical heaUh or 
emotional problems interfered with your normal social activities with 
family, friends, neighbors, or groups? 
Not at all Slightly Moderately Quite a bit Extremely 
u. O. 
7. How much bodily pain have you had during the past 4 weeks? 
l'1one Very mild :Mild Moderate Severe Very Severe 
O. 
8. Durblg the past 4 weeks, how much did. pain interfere with your normal 
work (including both work outside the home and housework)? 
Not at all A li.ttlebit Moderately Quite a bit Extremely 
OJ O. 
SF-36v2TWHcalth Survey © . 1996, 2000 by QualityMetric Incorpornted and Medical Outcomes Trust AIl Rights ReseI:Ved. 
$F-36® is a regis[ered ~~ark of Medical Outcoines Trust 
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9. These questions are about how you feel and how tbi~s have been with you 
during the past 4 weeks. For each question, please give the one answer 
tbat comes dosest to the way youbave been feeling~ How much of the time 
duIing the past 4 weeks ... 






~ Did you feel full ofiife? .. ... ... ... .. ............ ...... .... ... 01. ......... 02 ......... 03 .......... 04 ...... ... Os 
b ' Have you been very nervous? .......... .... .. ..... ...... .. 01 ...... .. .. 0 2 .......... 03 .......... 04 .. .. ... .. Os 
< Have you felt so dovm in the dumps 
. that nothing could cheer you up? .. ................ ... ... 01. .. .. .. ... Oi ........ -03 .. .. ...... 04 ....... .. Os 
d Have you felt calm and peaceful? .................. .. ... 01 ..... ..... 0 2 ........ .. 03 ...... .... 04 ..... .. .. Os 
c Did you have a lot of energy? .. .... .... ............ ... .... 01. ......... 02 .. .. .. .... 03 ... .. ..... 04 .. ....... Os 
f Have you felt downhearted and 
depressed? .... .. .. ... .. .... .. ... .......... ......... .... ....... ... .. .. 01 .. .... .. .. 02 .......... 03 .. .. ...... 04 ...... ... Os 
g Did you feel worn out? .. .. .. .... .. ......... .. .... .. ...... ..... 01. ......... 02 .. ........ 03 .... .. .... 04 .. .. .. .. . Os 
h Have you been happy? ..... .. ... .... .. .. .... .. ......... ....... 01. ..... .. .. 02 .......... 03 .......... 04 .. .. ..... Os 
i Did you feel tired? .... ...... .. .. .. ........ ..... .. .... .. .. ..... .. . 01 ........ .. 02 .......... 03 .... .... .. 04 ....... .. Os 
10. During the past 4 weeks, how much of the time has your physical health 
or emotional problems interfered with your social activities (like visiting 
friends, relatives, etc.)? 
All of the 
time 
Most of the 
time 
Some of the A little of the None of the 
time time time 
SF-36v2TM Health Survey © 1996, 2000 by QualityMetric Incorporated and Medical Outcomes Trust. All rughts ReseTVed. 
SF-36® is a registered trademark of Medical Outcomes Trust. 
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j 
11. How TRUE or FALSE is each of the following statements for you? 
Definitely Mostly 
true true 





than other people .................................... 01 ..... ....... 02 .. ......... 03 , .......... 04 ... ... ..... Os 
b I am as healthy as anybody I know ........ 01 ............ 02 .. .. ....... Q ........... 04 ......... .. Os 
< I expect my health to get worse .... .... ...... 01 .. .......... 02 .... .. .... . 03 .... ....... 04 ..... .... -.. 05 
d My health is excellent.. ...... .......... .. ... .... . 0, ............ 02 ..... .... .. O~ ........... 04 ........... D, 
THANK YOU FOR COMPLETING THESE OUEST/ONSI 
SF-36v2™ Health Survey © 1996;2000by QualityMctric Incorporated and Medical Outcomes Trust. All Rights Reserved. 
SF-36® is a registered trademark of Medica) Op!cornos Trust. . 
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APPENDIX C 
Have you been diagnosed with Osteoarthritis of 




Do you have pain associated with your 
Osteoarthritis? 
Are you not currently seeking treatment for your 
pain? 
Would you like to assist in furthering research on 
Magnetic Insoles and·their effect on pain and 
functional abilities? 
If you answer yes to the above questions you may be 
eligible to participate in our study and receive free 
foot ~creenings. 
: J~ 
'.' ~~ .. 
~ 
For more information contact Janice and Jenny at 
772-7600 
7 7 7 7 7 7 7 7 7 7 7 
7 7 7 7 7 7 7 7 7 7 7 
2 2 2 2 2 2 2 2 2 2 2 
7 7 7 7 7 7 7 7 7 7 7 
6 6 6 6 6 6 6 6 6 6 6 
0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 
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APPENDIXD 
University of North Dakota Human Subjects Review Form 
All research with human participants conducted by faculty, staff, and students associated with the University of North Dakota, 
must be reviewed and approved as prescribed by the University's policies and procedures governing the use of human subjects. 
It is the intent of the University of North Dakota (UND), through the Institutional Review Board (IRE) and Research 
Development and Compliance (RD&C), to assist investigators engaged in human subject research to conduct their research 
along ethical guidelines reflecting professional as well as community standards. The University has an obligation to ensure 
that all research involving human subjects meets regulations established by the United States Code of Federal Regulations 
(CFR). When completing the Human Subjects Review Form, use the "IRE Checklist" for additional guidance. 
Please provide the information requested below: 
Principal Investigator: Dr. Sue Jeno, PT, Janice Holth, Jenny Surma, Sarah Barendt 
Telephone: 701-777-2831 E-mail Address: sujeno@m~icine.nodak.edu ------------------------
Complete Mailing Address: P.O. Box 9037, UND Dept. of Physical Therapy, Grand Forks, ND 58202 
SchooVCollege: University of North Dakota Department: Physical Therapy 
--~------~-----------------
Student Adviser (if applicable): Dr. Sue Jeno -------------------------------------------------------
Telephone: 701-777-2831 E-mail Address: sujeno@medicine.nodak.edu 
Address or Box #: P.O. Box 9037, UND Department of Physical Terapy 
SchooVCollege: University of North Dakota Department: Physical Therapy 
Project Title: The Short-term Effects of Magnetic Insoles on Pain and Function in a Population with 
Lower Extremity Osteoarthritis: A Pilot Study 
Proposed Project Dates: Beginning Date: May 23, 2005 
----~--~---------
Completion Date: May 23, 2006 
--~~~~--~~-­(Including data analysis) 
Funding agencies supporting this research: University of North Dakota, Department of Physical Therapy 
(A copy o/the/unding proposal/or each agency identified above MUST be attached to this proposal when submitted.) 
Does the Principal Investigator or any researcher associated with this project have a financial interest 
in the results of this project? If yes, please submit, on a separate piece of paper, an additional 
YES or X NO explanation of the financial interest (other than receipt of a grant) 
If your project has been or will be submitted to other IRBs, list those Boards below, along with the status of each proposal. 
___________________ Date submitted: 
____________________ Date submitted: 
Type of Project: Check "Yes" or "No" for each of the following. 
X YES or NO New Project 
_____ Status: ___ Approved ___ Pending 
_____ Status: ___ Approved __ Pending 
YES or X NO Dissertationrrhesis 
YES or X NO ContinuationlRenewal X YES or NO Student Research Project 
Is this a Protocol Change for previously approved project? If yes, submit a signed copy of this form 
YES or X NO with the changes bolded or highlighted. 
Does your project involve medical record information? If yes, complete the HIP AA Compliance 
YES or X NO Application and submit it with this form. 
Does your project include Genetic Research? If yes, refer to Chapter 3 of the Researcher Handbook 
YES or X NO for additional guidelines regarding your topic. 
Does your project include Internet Research? If yes, refer to Chapter 3 of the Researcher Handbook 
YES or X NO for additional guidelines regarding your topic. 
Will subjects or data be provided by Altru Health Systems? If yes, submit two copies of the 
YES or X NO proposal. A copy of the proposal will be provided to Altru. 
X YES or 
Will research subjects be recruited at another organization (e.g., hospitals, schools, YMCA) or will 
NO assistance with the data collection be obtained from another organization? 
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If yes, list all institutions: Valley 400, Center Court Fitness, Select Therapy and Fitness, Grand Forks Senior Citizens' Center 
Letters fro"m each organization must accompany this proposal. Each letter must illustrate that the organization understands 
their involvement in that study, and agrees to participate in the study. Letters must include the name and title of the 
individual signing the letter and, if possible, should be printed on letterhead. 
Subject Classification: This study will involve subjects who are in the following special populations: Check all that apply. 
Minors « 18 years) UND Students 
Prisoners Pregnant W omenlFetuses 
Persons with impaired ability to understand their involvement and/or consequences of participation in this research 
_X __ Other Adults >18 years with diagnosed osteoarthritis of the hip and/or knee 
For information about protections for each of the special populations, refer to Chapter 5 of the Researcher Handbook. 
This study will involve: Check all that apply. 
___ Deception 
Radiation 
New Drugs (IND) 
___ Non-approved Use of Drug(s) 
Recombinant DNA 
X None of the above will be involved in this study 




Human Blood or Fluids 
Other 
Please provide a brief explanation (limit to 200 words or less) of the rationale and purpose of the study, introduction of any 
sponsor(s) of the study, and justification for use of human subjects and/or special populations (e.g., vulnerable populations such 
as minors, prisoners, pregnant women/fetuses). 
Magnetic therapy has been used for centuries for healing and reduction of pain from the ancient Greek usage of Loadstones to 
Mesmer's usage of magnetic iron rods. The effects of magnets on the human body include: reduction of fluid retention and 
inflammation, decreased pain, and increased circulation. In today's markets it is possible to buy magnetic de:.vices ranging from 
jewelry to mattress pads and from insoles to horse blankets. Magnetic insoles are marketed as being used for reducing pain in feet, 
legs, joints, and low back. Osteoarthritis pain is also closely correlated with decreased function. The purpose of this study is to 
evaluate the short-term effects of magnetic insoles on lower extremity osteoarthritis and function. The study will include 14 
participants with osteoarthritis, 2 randomly assigned groups of 7, who will wear over-the-counter magnetic insoles or generic non-
magnetic insoles for 2 weeks. For one week no insoles will be worn, and then the groups will switch and wear the other type of 
insole for 2 weeks. Function, pain, and foot status will be assessed prior to, during, and after treatment. Our goal is to evaluate the 
beneficial use of magnets to apply them to this patient population in a therapeutic setting. 
II. Protocol Description 
Please provide a succinct description of the procedures to be used by addressing the instructions under each of the following 
categories. Individuals conducting clinical research please refer to the "Guidelines for Clinical-Research Protocols" on the 
Research and Program Development website. 
1. Subject Selection. 
a) Describe recruitment procedures (i.e., how subjects will be re9ruited, who will recruit them, where and when they will be 
recruited and for how long) and include copies of any advertisements, fliers, etc., that will be used to recruit subjects. If 
incentive payments will be made to anyone for enrolling participants, describe the incentive package. 
Participants who have diagnosed lower extremity osteoarthritis will be voluntarily recruited from various local 
organizations including: Valley 400, Center Court Fitness, Select Therapy and Fitness, Grand Forks Senior Citizens' 
Center using fliers (see attached) put up at these establishments. 
b) Describe your subject selection procedures and criteria, paying special attention to the rationale for including subjects from 
any of the categories listed in the "Subject Classification" section above. 
Flyers will be posted in various chUrches, organizations, and fitness centers around the area to find subjects willing to 
participate in this research. Once potential subjects contact the investigators, a consent questionnaire will be administered 
to ensure participants are at minimal risk and qualified to meet the standards required to be included in the research. 
Subjects selected from the population will have physician diagnosed osteoarthritis of the hip(s) and/or knee(s) to fulfill our 
research goal to find out if magnetic insoles have any effect on pain and function in people with this condition and to " 
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further conclude if magnetic therapy may be used as an aspect of treatment to improve the lives of people with 
osteoarthritis. 
c) Describe your exclusionary criteria and provide a rationale for excluding subject categories. 
Exclusion criteria include: persons who are pregnant, have a pacemaker, cochlear implant, implanted insulin pump, or 
TENS unit, have open sores or are on anticoagulant medications, have a history of platelet disorder, myasthenia gravis, 
hyperthyroidism, autoimmune inflammatory disease, spinal neoplasm, cancer, and those individuals who fail an initial foot 
examination. Pregnant women are excluded because at this time the effects of magnets on fetuses are unknown. Those 
persons with implanted devices are excluded due to the fact that the magnetic fields may disrupt these devices. Due to the 
increased circulation that can be cased by magnets and the possibility of increased bleeding, those persons with open, 
bleeding sores, are on anticoagulants, or have a history of platelet disorder or cancer are excluded. People who fail the foot 
exam, or any subsequent foot exams throughout the study, will be excluded due to increased risk of co-morbidities and 
possible risks to further harm their foot health by using new orthotics for shoe wear. 
d) Describe the estimated number of subjects that will participate and the rationale for using that number of sUbjects. 
Approximately 14 participants are needed, with 7 participants randomly assigned in each of two groups. Fourteen 
participants was the amount chosen because this is a pilot study and statistical analysis needs to be performed on the data 
collected from these subjects. The number of subjects will be used to add power and validity to the statistical analysis of 
this study. 
e) Specify the potential for valid results. If you have used a power analysis to determine the number of subjects, describe 
your method. 
The results found with this study may either indicate further research or show no effects on pain and function in people with 
lower extremity osteoarthritis. 
2. Description of Methodology. 
a) Describe the procedures used to obtain informed consent. 
Prior to testing, participants will be asked to read and sign the attached consent form, and they will be provided with a 
copy of this form for their records. 
b) Describe where the research will be conducted. Document the resources and facilities to be used to carry out the proposed 
research. Please note staffing, funding, and space available to conduct this research. 
This study will take place in a private room at the University of North Dakota School of Medicine and Health Sciences in 
the Physical Therapy department, staffed by the investigators. The funding for this study is from the UND Department of 
Physical Therapy and the investigators. 
c) Indicate who will carry out the research procedures. 
Procedures will be carried out by Janice Holth, Jennifer Surma, and Sarah Barendt under the supervision of Dr. Sue Jeno, 
PT. 
d) Briefly describe the procedures and techniques to be used and the amount of time that is required by the subjects to 
complete them. 
Participants are asked to wear the shoes which they will wear for at least 8 hours each day during the study. During the 
first day of evaluation they will be asked to complete a pain assessment on the Visual Analog Scale (VAS), SF-36v2 
functional questionnaire, receive an initial foot examination, and sign the consent form. The participants will be given a 
copy of the consent form at that time. The investigators will then make a photocopy or tracing of their insoles from their 
shoes as to accurately size the insoles to be worn for the study. The investigators will fit their shoes with the insoles 
which have been randomly assigned to them. Once fit has been established, each will be given a wearing and activity log 
which they will be asked to record the hours they wear their shoes with the insoles each day and general activities 
performed while wearing the shoes with insoles. We ask that they try to wear them at least 8 hours per day during this 
study. This part of the study will take approximately 30-45 minutes. 
After one week we will call each particip'ant to ask for a pain assessment on the V AS and check the fit of the insoles. 
This will take approximately 5 miputes. 
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At the end of two weeks, we will reassess their pain on the VAS, and overall function by completing the SF-36v2. We 
will ask that they bring their wearing and activity log. The participation in this step should last approximately 20-30 
minutes. 
For a period of at least 1 week following the frrst trial, no insoles with be worn by the participants. At the end of this 
week, they will return to be refit with new insoles. They will give a pain assessment on the VAS, fill out the SF-36v2, 
and receive a new wearing and activity log. This step's participation should take approximately 30 minutes. 
Following a week of wearing the second pair of insoles, we will call each participant to ask for a pain assessment on the 
VAS and check the fit of the insoles. Participation in this call should take approximately 5 minutes. 
At the end of these 2 weeks, we will again reassess their pain on the VAS, and they will fill out the SF36v2. We will ask 
that they bring their wearing and activity log. Their feet will receive a final assessment at this time to ensure they have 
maintained the health of their feet. This portion of the study will take approximately 30 minutes. 
e) Describe audio/visual procedures and proper disposal of tapes. 
f) Describe the qualifications of the individuals conducting all procedures used in the study. 
Dr. Sue Jeno is on faculty in the PT Department and has training in the procedures utilized in this study. Janice Holth, 
Jenny Surma, and Sarah Barendt are second year students in the Doctor of Physical Therapy program at the University of 
North Dakota. They have taken coursework and are taking courses that give them the competency to perform the research 
proposed to fulfill their educational research project required to graduate from this program. They have been trained in the 
proper techniques of foot assessment and administration of the SF-36 and Visual Analog Scale for pain. 
g) Describe compensation procedures (payment or class credit for the subjects, etc.). 
The compensation for participation in this study will be the 2 pairs of insoles worn during the study and foot screenings. 
Attachments Necessary: Copies of all instruments (such as survey/interview questions, data collection forms completed by 
subjects, etc.) must be attached to this proposal. 
3. Risk Identification. 
a) Clearly describe the anticipated risks to the subject/others including any physical, emotional, and financial risks that might 
result from this study. 
The risks associated with this study are minimal, but these risks will be monitored and controlled. Limited physical risks 
could include foot pain, blisters, or tingling. Emotional risks may include the subjects becoming slightly discouraged if 
anticipating an improvement in their condition and these benefits are not achieved. Proper subject screening and foot 
assessments will be completed prior to the study to minimize these possible risks. 
b) Indicate whether there will be a way to link subjec~ responses and/or data sheets to consent forms, and if so, what the 
justification is for having that link. 
To maintain confidentiality, participants are identified by a numerical code only with data stored in separate, locked 
cabinets within the Department of Physical Therapy. Information will only be presented in aggregate form and identifiable 
only to the investigators and advisor of this study for data analysis purposes. 
4. Subject Protection. 
a) Describe precautions you will take to minimize potential risks to the subjects (e.g., sterile conditions, informing subjects 
that some individuals may have strong emotional reactions to the procedures, debriefing, etc.). 
Subjects will be informed of the procedures, purpose, and time involved in this study prior to participation. Subjects will 
sign a consent form and be provided a copy for their records. Subjects will be informed that they may withdraw from the 
study at any time without any repercussions. Foot assessments will be performed prior to and throughout the study to 
maintain foot quality and ensure participants who enter the study have healthy feet. Fit of insoles will also be reassessed 
throughout the study to prevent potential risks associated with wearing the insoles. 
b) Describe procedures you will implement to protect confidentiality (such as coding subject data, removing identifying 
information, reporting data in aggregate form, etc.). 
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To maintain confidentiality, participants are identified by a numerical code only and data will be stored separate from 
consent forms in locked file cabinets within the Department of Physical Therapy. Information will only be presented in 
aggregate form and identifiable only to the investigators and advisor of this study. 
c) Indicate that the subject will be provided with a copy of the consent form and how this will be done. 
Each subject will be provided a copy of the consent form personally from the investigators at the first visit, prior to 
beginning the study. 
d) Describe the protocol regarding record retention. Please indicate that research data from this study and consent forms 
will both be retained in separate locked locations for a minimum of three years following the completion of the study. 
Describe: 1) the storage location of the research data (separate from consent forms and subject personal data) 
2) who will have access to the data 
3) how the data will be destroyed 
4) the storage location of consent forms and personal data (separate from research data) 
5) how the consent forms will be destroyed 
Data will be stored separate from consent forms in locked file cabinets within the Department of Physical Therapy. The 
only people who will have access to this information being the investigators, advisor, and IRE auditing staff. Data will 
be kept for three years after the completion of the study, at which time the information will be shredded. 
e) Describe procedures to deal with adverse reactions (referrals to helping agencies, procedures for dealing with trauma, etc.). 
In the event that this research activity results in a physical injury, medical treatment will be readily available, including 
first aid, emergency treatment and follow-up care as it is to any member of the general public in similar circumstances. 
Payment for any treatment must be provided by the subject or the subject's third party payer, if applicable. 
f) Include an explanation of medical treatment available if injury or adverse reaction occurs and responsibility for costs 
involved. 
In the unlikely event that this research activity results in injury, medical treatment will be available, including first aid, 
emergency treatment and follow-up care as it is to the general public in similar circumstances. The pt:rson and their third 
party payer must provide payment for any such treatment. 
III. Benefits of the Study 
Clearly describe the benefits to the subject and to society resulting from this study (such as learning experiences, services 
received, etc.). Please note: payment is not a benefit and should be listed in the Protocol Description section under 
Methodology. 
Advancement of research in the area of the use of magnetic insoles in the therapeutic setting is the ultimate goal of this study. 
The participants will learn about magnetic therapy and potentially experience its positive effects on their osteoarthritis pain and 
function. The knowledge gained in this study may aid all involved in their future decisions regarding the use of magnetic 
therapy. 
IV. Consent Form 
A copy of the consent form must be attached to this proposal. If no consent form is to be used, document the procedures to be 
used to protect human subjects. Refer to the RD&C website for further information regarding consent form regulations. 
Please note: Regulations require that all consent forms, and all pages of the consent forms, be kept for a minimum of 3 
years after the completion of the study, even if the subject does not continue participation. 
By signing below, you are verifying that the information provided in the Human Subjects Review Form and attached 
information is accurate and that the project will be completed as indicated. 
Signatures: 
(principal Investigator) Date: 
(Student Adviser) Date: 
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REPORT OF ACTION: EXEMPT/EXPEDITED REVIEW 
University of North Dakota Institutional Review Board 
Date: 5/6/2005 Project Number: IRB-200505-363 
Principal Investigator: Jeno, Sue; Holth, Janice; Surma, Jenny; Barendt, Sarah 
Department: Physical Therapy 
Project Title: The Short-Term Effects of Magnetic Insoles on Pain and Function in a Population with Lower Extremity 
Osteoarthritis: A Pilot Study 
The above referenced project was reviewed by a designated member for the University's Institutional Review Board 
on ' May 9, 2005 and the following action was taken: 
-d Project approved. Expedited Review Category No. _____ tft---· ________________ _ 
'1J Next scheduled review must be before: _.!-'M""aJ-y--",8 ... , -""2"'-0"'-0"'-6 ____________________ _ 
¢ Copies of the attached consent form with the IRS approval stamp dated ...,M....ea"-vJ-..,9<...,'--'2=-'0""O,.,,5<--_____ _ 
. must be used in obtaining consent for this study. 
Project approved. Exempt Review Category No. _______________________ _ 
o This approval is valid until as long as approved procedures are followed. No 
periodic review scheduled unless so stated in the Remarks Section. 
o Copies of the attached consent form with the IRS approval stamp dated 
must be used in obtaining consent for this study. 
o Minor modifications required . The required corrections/additions must be submitted to ROC for review and 
approval. This study may NOT be started UNTIL final IRS approval has been received. 
(See Remarks Section for further information.) i 
o Project approval deferred. This study may not be started until final IRS approval has been received. 
(See Remarks Section for further information.) 
REMARKS: Any unanticipated problem or adverse occurrence in the course of the research project must be 
reported within 72 hours to the IRS Chairperson or ROC by submitting an Unanticipated 
Problem/Adverse Event Form. 
Any changes in protocol or Consent Forms must receive IRS approval prior to being 
implemented. You must submit a Protocol Change Form with all revised research documents 
to include changes to protocol, consent forms, or supportive materials, with the appropriate 
signatures, to Research Development and Compliance for review and approval. 
PLEASE NOTE: Requested revisions for student proposals MUST include adviser's signature. All revisions 
MUST be highlighted. 
~ducation Requirements Completed. (Project cannot be started until IRS education requirements are met.) 
cc: Chair, Physical Therapy; Dean, School of 
Medicine 
If the proposed project (clinical medical) is to be part of a research activity funded by a Federal Agency, a special assurance 




ID# ___ _ 
Magnetic Insoles 
Foot Assessment 
1. Are the nails thick, too long, ingrown, or infected with fungal disease? Y N 






Prominent Metatarsal Heads 
Amputation __ Specify date, side and level ______ _ 




4. Skin Condition: (Measure, draw in and label on foot diagram) 
C = Callus S = Swelling 
PU = Pre-ulcerative lesion U = Ulcer 
R = Redness D = Dryness 
W=Warmth 
5. Protective Sensation: label with + if participant can feel 4.5 g. monofilament or - if 
participant can not feel filament in circled areas. 




Birthday: ____ _ 
Gender: M F 
Height ___ _ 
Weight __ _ 
Shoe Size: ___ _ 
Magnetic Insoles 
Participation Survey 
Do you have osteoarthritis pain in your hip(s) or knee(s)? Yes No 
In whichjoint(s) is your osteoarthritis pain? _______________ _ 
Are you currently seeking medical treatment for your osteoarthritis pain?: Yes No 
How would you describe your pain today? _______________ _ 
How long have you been experiencing this pain? ____________ _ 
What Medications are you currently taking? ______________ _ 
Have you ever worn magnetic insoles? Yes No 
Do you believe in magnetic therapy for relieving pain? Yes No 
Have you had a joint arthroplasty/replacement? Yes No 
If yes, which joint(s)? __________________ _ 
Please Circle any that apply to you: 
Pregnant Pacemaker Cochlear Implant 
TENS unit Insulin Pump 
Platelet Disorder Spinal Neoplasm Cancer 
Myasthenia Gravis Hyperthyroidism 




The Short-term Effects of Magnetic Insoles on Pain and Function in a population with 
Lower Extremity Osteoru1hritis: A Pilot Study 
Participant Information and Consent Form 
You are invited to participate in a student research study conducted by Janice Holth, 
Jennifer Surma, and Sarah Alberts Barendt and faculty advisor, Dr. Sue Jeno, PT of the 
University of North Dakota Department of Physical Therapy. The purpose of this study 
is to evaluate the effects of magnetic insoles on pain and function of people with 
osteoarthritis. 
Healthy individuals who do not meet any of the exclusion criteria can be included in this 
study. Reasons to be excluded from this study include: persons who are pregnant, have 
an implanted devise, have open sores or are on anticoagulant medications, have a history 
of platelet disorder, myasthenia gravis, hyperthyroidism, autoimmune inflammatory 
disease, spinal neoplasm, cancer. The effects of magnets on the involved structures with 
these diagnoses are detrimental to the health of the participant or are unknown at this 
time leading to the exclusion of these individuals. Also, if problems are noted during 
initial foot assessment, participants will also be excluded. 
You will be asked to come to the Dept. of Physical Therapy 4 times during the study. 
During the first day of evaluation you will be asked to sign this consent form and 
complete the participant survey as well as the pain and function questionnaires. You are 
asked to wear or bring the shoes you plan on wearing for the study so the investigators 
can assess size and fit your shoes with the insoles randomly assigned to you, magnetic or 
non-magnetic. A foot assessment will be completed at this time to assess sensation and 
possible complications to wearing the insoles. This part of the study will take 
approximately 30-45 minutes of your time. 
You will be given a wearing and activity log which you will be asked to record the hours 
you wear your shoes with the insoles each day and general activities performed while 
wearing the shoes with insoles. We ask that you try to wear these shoes with the insoles 
for at least 8 hours per day during this study. After one week, you will receive a phone 
call from one of the investigators who will ask about your pain and make sure the insoles 
still fit. At the end of two weeks, you will return to UND and we will again reassess your 
pain and overall function. We will ask that you bring your wearing and activity log to the 
investigators. You will again complete the pain and function questionnaires and a foot 
assessment will be done to make sure no changes or sores have occurred. The 
participation in this step should last approximately 20-30 minutes. 
You will then spend at least one week without any insoles. After which, you will return 
to be refit with new insoles, either magnetic or non-magnetic. You will have your feet 
reassessed and receive a new wearing and activity log. This step's participation should 
take approximately 30 minutes. After one week, you will again receive a phone call from 
one of the investigators to assess your pain and the fit of the insoles. At the end of two 
weeks, we will reassess your pain and overall function and one last time. We will ask 
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that you bring with you to UND, your wearing and activity log and you will again 
complete the pain and function questionnaires. Your feet will be reassessed at this time 
to ensure health of feet has been maintained. This portion of the study will take 
approximately 30 minutes. You will be able to keep the insoles you wore as part of this 
study. 
The benefits to you, the participant, is possibly experiencing the effects of magnetic 
insoles, as well as assisting in medical research which will further the knowledge on the 
legitimate uses for magnetic insoles with persons experiencing pain from osteoarthritis. 
This study will last 6 weeks, and your compensation will be the insoles worn in this 
study. 
The anticipated risks associated with participation in this study are minimal and may 
involve changes in the condition of your feet. We request that you wear socks with your 
shoes and contact the investigators immediately if you feel any discomfort. The foot 
assessments are designed to minimize the risk of these problems. If any problems are 
developing during the study, you will be removed from the study and referred as 
necessary. Basic first aid or emergency treatment will be available as needed as it would 
be for the general public and any medical attention will not be covered by this institution 
and will have to be covered by you or your third party payer. To maintain 
confidentiality, all personal data will be assigned a numerical code, and data from this 
study will be stored in locked file cabinets within the Department of Physical Therapy for 
three years, after which time it will be shredded. Only the researchers, the advisor, and 
people who audit IRB procedures will have access to the data. 
Your participation in this study is completely voluntary. Your decision whether or not to 
participate in this study will in no way change any future relations with UND. If you do 
choose to participate in this study, you or the researches can choose to terminate 
participation at any time without penalty. There are no anticipated costs for participation 
in this study and you will receive a copy of this consent form for you records. 
If you have any question or concerns about this study at any time, please do not hesitate 
to contact Dr. Sue Jeno at 777-2831, Janice Holth and Jennifer Surma at 772-7600, Sarah 
Alberts Barendt at 885-5110, or Research Development and Compliance at 777-4279. 
ALL OF MY QUESTIONS HA VB BEEN ANSWERED AND I AM ENCOURAGED 
TO ASK ANY QUESTIONS THAT I MAY HA VB CONCERNING THIS STUDY IN 
THE FUTURE. MY SIGNATURE INDICATES THAT, HAVING READ THE 
ABOVE INFORMATION; I HA VB DECIDED TO PARTICIPATE IN THE 
RESEARCH PROJECT. 
Participant Date 
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